News

FOXO Technologies Subsidiary, Myrtle Recovery Centers, Receives Two Full Licenses from the Tennessee Department of Mental Health and Substance Abuse Services

MINNEAPOLIS, MN, Aug. 08, 2024 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company”), today announced that its recently acquired subsidiary, Myrtle Recovery Centers, Inc. (“Myrtle”), has been granted two full licenses from the Tennessee Department of Mental Health and Substance Abuse Services, effective August 1, 2024, for 12 months. The first license authorizes the provision of services for alcohol and drug residential detoxification treatment, as well as alcohol and drug residential rehabilitation treatment. The second license authorizes the provision of services for non-residential office-based opiate treatment.

08/08/2024

FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements

Reaffirms commitment to regaining compliance with the NYSE American continued listing standards Reaffirms commitment to regaining compliance with the NYSE American continued listing standards

07/16/2024

Profitability

Dividends

Income Statement

Balance Sheet

Cash Flow Statement

Symbol Frequently Asked Questions

Is FOXO Technologies Inc. (FOXO) a buy, sell, or hold?

FOXO Technologies Inc. (FOXO) can sell. Click on Rating Page for detail.

What is FOXO Technologies Inc.'s stock price?

The price of FOXO Technologies Inc. (FOXO) is 0.79 and it was updated on 2024-11-06 13:00:41.

Is FOXO Technologies Inc. (FOXO) overvalued or undervalued?

Currently FOXO Technologies Inc. (FOXO) is in undervalued.

News

From:

To:

News
FOXO Technologies Inc. Secures Up to $2.8 Million in Senior Notes to Fund Previously Announced Acquisition of Myrtle Recovery Centers, Inc. and Provide Additional Working Capital MINNEAPOLIS, MN, June 18, 2024 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company” or “FOXO”), today announced that it has secured up to $2.8 million in Senior Notes from an institutional investor (“Investor”) to fund the previously announced acquisition of Myrtle Recovery Centers, Inc. as well as provide additional working capital to support the Company's growth strategy. Tue, Jun. 18, 2024
FOXO Technologies Enters into Share Exchange Agreements to Acquire Healthcare Operations from Rennova Health, Inc. Acquisition expected to be synergistic with FOXO's epigenetic technology in community health and addiction recovery settings as well as contribute significant cash flow Acquisition expected to be synergistic with FOXO's epigenetic technology in community health and addiction recovery settings as well as contribute significant cash flow Fri, Jun. 14, 2024
Why Is Foxo Technologies (FOXO) Stock Up 55% Today? Foxo Technologies (NYSEMKT: FOXO ) stock is up on Friday after the epigenetic biomarkers technology company announced two acquisition deals. The first deal announced by Foxo Technologies is with Myrtle Recovery Centers. Fri, Jun. 14, 2024
FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements Reaffirms commitment to regaining compliance with the NYSE American continued listing standards Reaffirms commitment to regaining compliance with the NYSE American continued listing standards Tue, Apr. 23, 2024
7 AI Penny Stocks to Double Your Money: February 2024 Penny stocks representing companies integrating AI into products and services hold particularly interesting upside. Penny Shares are known to move upward rapidly and the emergence of AI continues to produce rapid gains. Fri, Feb. 23, 2024

SEC Filings

SEC Filings
FOXO Technologies Inc. (FOXO) - D SEC Filings 10/29/2024
FOXO Technologies Inc. (FOXO) - D SEC Filings 10/28/2024
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 10/25/2024
FOXO Technologies Inc. (FOXO) - PRE 14A SEC Filings 10/24/2024
FOXO Technologies Inc. (FOXO) - D SEC Filings 10/23/2024
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 10/23/2024
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 10/18/2024
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 10/15/2024
FOXO Technologies Inc. (FOXO) - SC 13D/A SEC Filings 09/23/2024
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 09/12/2024
FOXO Technologies Inc. (FOXO) - 3 SEC Filings 09/12/2024
FOXO Technologies Inc. (FOXO) - 8-K/A - Current report SEC Filings 08/28/2024
FOXO Technologies Inc. (FOXO) - 10-Q - Quarterly Report SEC Filings 08/19/2024
FOXO Technologies Inc. (FOXO) - NT 10-Q - Quarterly Report SEC Filings 08/14/2024
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 08/14/2024
FOXO Technologies Inc. (FOXO) - D SEC Filings 08/09/2024
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 08/08/2024
FOXO Technologies Inc. (FOXO) - SC 13D SEC Filings 08/05/2024
FOXO Technologies Inc. (FOXO) - PRE 14A SEC Filings 07/31/2024
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 07/31/2024
FOXO Technologies Inc. (FOXO) - SC 13D/A SEC Filings 07/24/2024
FOXO Technologies Inc. (FOXO) - 4 SEC Filings 07/24/2024
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 07/23/2024
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 07/16/2024
FOXO Technologies Inc. (FOXO) - 10-Q - Quarterly Report SEC Filings 06/28/2024
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 06/26/2024
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 06/18/2024
FOXO Technologies Inc. (FOXO) - 8-K/A - Current report SEC Filings 06/14/2024
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 06/14/2024
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 06/13/2024
FOXO Technologies Inc. (FOXO) - 10-K - Current report SEC Filings 06/06/2024
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 06/04/2024
FOXO Technologies Inc. (FOXO) - 10-Q/A - Quarterly Report SEC Filings 06/04/2024
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 06/03/2024
FOXO Technologies Inc. (FOXO) - D SEC Filings 05/14/2024
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 05/09/2024
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 04/23/2024
FOXO Technologies Inc. (FOXO) - NT 10-K - Current report SEC Filings 04/01/2024
FOXO Technologies Inc. (FOXO) - D SEC Filings 03/20/2024
FOXO Technologies Inc. (FOXO) - SC 13G/A SEC Filings 02/20/2024
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 02/16/2024
FOXO Technologies Inc. (FOXO) - SC 13D SEC Filings 02/15/2024
FOXO Technologies Inc. (FOXO) - D SEC Filings 02/12/2024
FOXO Technologies Inc. (FOXO) - SC 13D/A SEC Filings 02/09/2024
FOXO Technologies Inc. (FOXO) - 424B3 SEC Filings 02/08/2024
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 02/07/2024
FOXO Technologies Inc. (FOXO) - 4 SEC Filings 02/07/2024
FOXO Technologies Inc. (FOXO) - SC 13D SEC Filings 02/05/2024
FOXO Technologies Inc. (FOXO) - 3 SEC Filings 02/05/2024
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 01/25/2024
FOXO Technologies Inc. (FOXO) - 424B3 SEC Filings 01/23/2024
FOXO Technologies Inc. (FOXO) - 3 SEC Filings 01/23/2024
FOXO Technologies Inc. (FOXO) - 4 SEC Filings 01/22/2024
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 01/19/2024
FOXO Technologies Inc. (FOXO) - 10-Q - Quarterly Report SEC Filings 01/19/2024
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 01/05/2024
FOXO Technologies Inc. (FOXO) - 4/A SEC Filings 12/26/2023
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 12/19/2023
FOXO Technologies Inc. (FOXO) - 4 SEC Filings 12/18/2023
FOXO Technologies Inc. (FOXO) - SC 13G SEC Filings 12/08/2023
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 11/27/2023
FOXO Technologies Inc. (FOXO) - NT 10-Q - Quarterly Report SEC Filings 11/15/2023
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 11/13/2023
FOXO Technologies Inc. (FOXO) - 424B3 SEC Filings 11/13/2023
FOXO Technologies Inc. (FOXO) - 424B3 SEC Filings 11/03/2023
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 11/02/2023
FOXO Technologies Inc. (FOXO) - EFFECT SEC Filings 10/30/2023
FOXO Technologies Inc. (FOXO) - 424B3 SEC Filings 10/30/2023
FOXO Technologies Inc. (FOXO) - S-1/A SEC Filings 10/25/2023
FOXO Technologies Inc. (FOXO) - 8-K/A - Current report SEC Filings 10/25/2023
FOXO Technologies Inc. (FOXO) - 424B3 SEC Filings 10/25/2023
FOXO Technologies Inc. (FOXO) - S-1 SEC Filings 10/18/2023
FOXO Technologies Inc. (FOXO) - SC 13G/A SEC Filings 10/17/2023
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 10/16/2023
FOXO Technologies Inc. (FOXO) - 424B3 SEC Filings 10/16/2023
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 10/05/2023
FOXO Technologies Inc. (FOXO) - 424B3 SEC Filings 10/05/2023
FOXO Technologies Inc. (FOXO) - 4 SEC Filings 10/05/2023
FOXO Technologies Inc. (FOXO) - 3 SEC Filings 09/29/2023
FOXO Technologies Inc. (FOXO) - 424B3 SEC Filings 09/21/2023
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 09/19/2023
FOXO Technologies Inc. (FOXO) - D/A SEC Filings 09/12/2023
FOXO Technologies Inc. (FOXO) - 424B3 SEC Filings 09/08/2023
FOXO Technologies Inc. (FOXO) - EFFECT SEC Filings 09/07/2023
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 09/07/2023
FOXO Technologies Inc. (FOXO) - 424B3 SEC Filings 09/06/2023
FOXO Technologies Inc. (FOXO) - S-1/A SEC Filings 09/05/2023
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 08/31/2023
FOXO Technologies Inc. (FOXO) - 424B3 SEC Filings 08/31/2023
FOXO Technologies Inc. (FOXO) - S-1 SEC Filings 08/25/2023
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 08/23/2023
FOXO Technologies Inc. (FOXO) - 424B3 SEC Filings 08/23/2023
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 08/18/2023
FOXO Technologies Inc. (FOXO) - 424B3 SEC Filings 08/18/2023
FOXO Technologies Inc. (FOXO) - SC 13G SEC Filings 08/11/2023
FOXO Technologies Inc. (FOXO) - 424B3 SEC Filings 08/11/2023
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 08/10/2023
FOXO Technologies Inc. (FOXO) - 10-Q - Quarterly Report SEC Filings 08/10/2023
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 08/08/2023
FOXO Technologies Inc. (FOXO) - 424B3 SEC Filings 08/08/2023
FOXO Technologies Inc. (FOXO) - SC 13G/A SEC Filings 08/07/2023
FOXO Technologies Inc. (FOXO) - EFFECT SEC Filings 08/04/2023
FOXO Technologies Inc. (FOXO) - 424B3 SEC Filings 08/03/2023
FOXO Technologies Inc. (FOXO) - S-1/A SEC Filings 07/31/2023
FOXO Technologies Inc. (FOXO) - D SEC Filings 07/28/2023
FOXO Technologies Inc. (FOXO) - S-1 SEC Filings 07/21/2023
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 07/21/2023
FOXO Technologies Inc. (FOXO) - 424B3 SEC Filings 07/21/2023
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 07/20/2023
FOXO Technologies Inc. (FOXO) - 4 SEC Filings 07/18/2023
FOXO Technologies Inc. (FOXO) - EFFECT SEC Filings 07/07/2023
FOXO Technologies Inc. (FOXO) - 424B3 SEC Filings 07/06/2023
FOXO Technologies Inc. (FOXO) - SC 13G/A SEC Filings 06/26/2023
FOXO Technologies Inc. (FOXO) - 3 SEC Filings 06/26/2023
FOXO Technologies Inc. (FOXO) - S-8 SEC Filings 06/23/2023
FOXO Technologies Inc. (FOXO) - S-1 SEC Filings 06/23/2023
FOXO Technologies Inc. (FOXO) - SC 13G SEC Filings 06/22/2023
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 06/22/2023
FOXO Technologies Inc. (FOXO) - 424B3 SEC Filings 06/22/2023
FOXO Technologies Inc. (FOXO) - 424B3 SEC Filings 06/20/2023
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 06/16/2023
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 06/15/2023
FOXO Technologies Inc. (FOXO) - D SEC Filings 06/08/2023
FOXO Technologies Inc. (FOXO) - SC 13G SEC Filings 06/02/2023
FOXO Technologies Inc. (FOXO) - 3 SEC Filings 06/02/2023
FOXO Technologies Inc. (FOXO) - SC TO-I/A SEC Filings 05/30/2023
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 05/30/2023
FOXO Technologies Inc. (FOXO) - 424B3 SEC Filings 05/30/2023
FOXO Technologies Inc. (FOXO) - 25-NSE SEC Filings 05/24/2023
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 05/17/2023
FOXO Technologies Inc. (FOXO) - 424B3 SEC Filings 05/17/2023
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 05/11/2023
FOXO Technologies Inc. (FOXO) - 424B3 SEC Filings 05/11/2023
FOXO Technologies Inc. (FOXO) - 10-Q - Quarterly Report SEC Filings 05/11/2023
FOXO Technologies Inc. (FOXO) - EFFECT SEC Filings 05/08/2023
FOXO Technologies Inc. (FOXO) - 424B4 SEC Filings 05/08/2023
FOXO Technologies Inc. (FOXO) - SC TO-I/A SEC Filings 05/05/2023
FOXO Technologies Inc. (FOXO) - DEF 14A SEC Filings 05/04/2023
FOXO Technologies Inc. (FOXO) - ARS SEC Filings 05/04/2023
FOXO Technologies Inc. (FOXO) - SC TO-I SEC Filings 04/27/2023
FOXO Technologies Inc. (FOXO) - S-1 SEC Filings 04/27/2023
FOXO Technologies Inc. (FOXO) - PRE 14A SEC Filings 04/24/2023
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 04/18/2023
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 03/31/2023
FOXO Technologies Inc. (FOXO) - 10-K - Current report SEC Filings 03/31/2023
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 03/20/2023
FOXO Technologies Inc. (FOXO) - 424B3 SEC Filings 03/20/2023
FOXO Technologies Inc. (FOXO) - SC TO-C SEC Filings 03/10/2023
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 03/10/2023
FOXO Technologies Inc. (FOXO) - 424B3 SEC Filings 03/10/2023
FOXO Technologies Inc. (FOXO) - EFFECT SEC Filings 02/15/2023
FOXO Technologies Inc. (FOXO) - 424B4 SEC Filings 02/15/2023
FOXO Technologies Inc. (FOXO) - SC 13G/A SEC Filings 02/14/2023
FOXO Technologies Inc. (FOXO) - S-1/A SEC Filings 02/10/2023
FOXO Technologies Inc. (FOXO) - SC 13G/A SEC Filings 02/09/2023
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 02/08/2023
FOXO Technologies Inc. (FOXO) - 8-K/A - Current report SEC Filings 02/06/2023
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 02/03/2023
FOXO Technologies Inc. (FOXO) - 3 SEC Filings 02/03/2023
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 02/02/2023
FOXO Technologies Inc. (FOXO) - S-1/A SEC Filings 01/30/2023
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 01/12/2023
FOXO Technologies Inc. (FOXO) - 8-K/A - Current report SEC Filings 01/06/2023
FOXO Technologies Inc. (FOXO) - S-8 SEC Filings 12/23/2022
FOXO Technologies Inc. (FOXO) - S-1 SEC Filings 12/23/2022
FOXO Technologies Inc. (FOXO) - 10-Q - Quarterly Report SEC Filings 11/21/2022
FOXO Technologies Inc. (FOXO) - NT 10-Q - Quarterly Report SEC Filings 11/15/2022
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 11/15/2022
FOXO Technologies Inc. (FOXO) - D SEC Filings 10/05/2022
FOXO Technologies Inc. (FOXO) - 25 SEC Filings 10/03/2022
FOXO Technologies Inc. (FOXO) - CERT SEC Filings 09/29/2022
FOXO Technologies Inc. (FOXO) - SC 13D/A SEC Filings 09/26/2022
FOXO Technologies Inc. (FOXO) - SC 13D SEC Filings 09/26/2022
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 09/26/2022
FOXO Technologies Inc. (FOXO) - 25 SEC Filings 09/26/2022
FOXO Technologies Inc. (FOXO) - 4 SEC Filings 09/22/2022
FOXO Technologies Inc. (FOXO) - 3 SEC Filings 09/22/2022
FOXO Technologies Inc. (FOXO) - 8-K - Current report SEC Filings 09/21/2022
FOXO Technologies Inc. (FOXO) - 4 SEC Filings 09/16/2022
FOXO Technologies Inc. (FOXO) - 3 SEC Filings 09/16/2022
FOXO Technologies Inc. (FOXO) - CORRESP SEC Filings 08/25/2022
FOXO Technologies Inc. (FOXO) - CORRESP SEC Filings 08/24/2022
FOXO Technologies Inc. (FOXO) - UPLOAD SEC Filings 08/23/2022
FOXO Technologies Inc. (FOXO) - CORRESP SEC Filings 08/12/2022
FOXO Technologies Inc. (FOXO) - UPLOAD SEC Filings 08/01/2022
FOXO Technologies Inc. (FOXO) - CORRESP SEC Filings 07/08/2022
FOXO Technologies Inc. (FOXO) - UPLOAD SEC Filings 06/16/2022
FOXO Technologies Inc. (FOXO) - UPLOAD SEC Filings 05/27/2022
FOXO Technologies Inc. (FOXO) - CORRESP SEC Filings 05/13/2022
FOXO Technologies Inc. (FOXO) - UPLOAD SEC Filings 05/05/2022
FOXO Technologies Inc. (FOXO) - 5 SEC Filings 02/16/2021

Press Releases

StockPrice Release
Foxo technologies subsidiary, myrtle recovery centers, receives two full licenses from the tennessee department of mental health and substance abuse services 08/08/2024
Foxo technologies inc. announces receipt of notice of non-compliance with nyse continued listing requirements 07/16/2024
Foxo technologies inc. secures up to $2.8 million in senior notes to fund previously announced acquisition of myrtle recovery centers, inc. and provide additional working capital 06/18/2024
Foxo technologies enters into share exchange agreements to acquire healthcare operations from rennova health, inc. 06/14/2024
Foxo technologies inc. announces receipt of notice of non-compliance with nyse continued listing requirements 04/23/2024
Foxo technologies announces non-binding agreement for potentially transformative merger with m2i global 02/14/2024
Foxo technologies announces appointment of capital markets veteran francis colt dewolf to the board of directors 01/25/2024
Foxo technologies formalizes license agreement with kr8.ai to power new epigenetic wellness solutions 01/22/2024
Foxo technologies inc. announces receipt of notice of non-compliance with nyse continued listing requirements 12/19/2023
Foxo technologies on track to commence commercial rollout of vithar™ ai health coach in early 2024 12/01/2023
Foxo technologies receives notice from nyse american regarding late filing of quarterly report on form 10-q 11/29/2023
Foxo technologies provides reminder for webinar to be held today, november 10th at 10 am eastern time, to unveil vithar™ ai health coach 11/10/2023
Foxo technologies to unveil vithar™ ai health coach; schedules webinar for friday, november 10th at 10 am eastern time 11/08/2023
Foxo technologies expects class a common stock to resume trading, today, november 7, in connection with 1-for-10 reverse stock split 11/07/2023
Foxo technologies unveils plans for new direct-to consumer offering combining the company's epigenetic data with the power of ai 10/30/2023
Foxo technologies inc. announces reverse stock split 10/27/2023
Foxo technologies completes strategic alternatives review and outlines latest progress executing corporate strategy 10/23/2023
Foxo technologies announces issue notification from uspto for a patent leveraging machine learning approaches to enable the commercialization of epigenetic biomarkers 10/13/2023
Foxo technologies™ interim ceo mark white provides letter to shareholders outlining new ai-enabled direct-to-consumer strategy and immediate expense reductions 10/06/2023
Foxo technologies announces agreement with atrio insurance 09/06/2023
Foxo technologies inc. announces nyse american acceptance of compliance plan 08/31/2023
Foxo technologies inc. announces receipt of second notice of non-compliance from nyse american 08/18/2023
Foxo technologies™ collaborates with datarobot to pave the way for ai-driven epigenetic biomarker research in human longevity 08/17/2023
Foxo technologies™ announces second quarter 2023 financial results 08/10/2023
Foxo technologies™ sets second quarter 2023 business update call for thursday, august 10, 2023 at 3:15 p.m. ct 08/08/2023
Longevity biotech companies gero and foxo technologies™ to embark on joint initiative on artificial intelligence and epigenetic data to discover signatures of human health trajectories 08/07/2023
Foxo technologies launches bioinformatics services to revolutionize epigenetic data analysis 07/19/2023
Foxo technologies inc. announces receipt of notice of non-compliance with nyse continued listing requirements 06/16/2023
Foxo technologies announces results of annual stockholders meeting 05/30/2023
Nyse american has commenced delisting proceedings in the foxo ws warrants of foxo technologies inc. 05/17/2023
Foxo technologies™ announces first quarter 2023 financial results 05/11/2023
Foxo technologies inc. (foxo) class acton alert: robbins llp reminds investors of lead plaintiff deadline in class action against foxo technologies inc. 04/17/2023
Shareholder alert: robbins llp informs investors of class action against foxo technologies inc. (foxo) 03/31/2023
Foxo life™ to begin distribution relationship with amsuisse to sell life insurance designed to keep you alive™ 12/08/2022
Foxo technologies announces filing of form 10-q for the third quarter 2022 11/23/2022
Foxo technologies announces management changes and delays filing of form 10-q 11/15/2022
Foxo technologies postpones third quarter 2022 earnings report and conference call 11/14/2022
Foxo technologies announces agreement with haven life 11/14/2022
Foxo technologies announces first distribution partner and begins product rollout in california; expands executive team with insurance industry talent 10/12/2022

More Headlines

News
FOXO Technologies Announces Non-Binding Agreement for Potentially Transformative Merger with M2i Global Proposed Combination to Focus on Securing Our Nation's Supply to Critical Materials and Resources Proposed Combination to Focus on Securing Our Nation's Supply to Critical Materials and Resources 02/14/2024
FOXO Technologies Announces Appointment of Capital Markets Veteran Francis Colt deWolf to the Board of Directors MINNEAPOLIS--(BUSINESS WIRE)--FOXO Technologies Inc. (NYSE American: FOXO) (the “Company”), today announced the appointment of Francis Colt deWolf to the Company's Board of Directors. Mr. deWolf III brings over 20 years of experience in the financial services Sector. He currently serves as President of Colt Capital LLC, a Florida-based company, whose principal activities focus on advising emerging market companies on private and public financing strategies. Prior to founding Colt Capital LLC, M. 01/25/2024
FOXO Technologies Formalizes License Agreement with KR8.ai to Power New Epigenetic Wellness Solutions MINNEAPOLIS--(BUSINESS WIRE)--FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”), a leader in the field of commercializing epigenetic biomarker technology, today announced it has formalized its collaboration with KR8.ai Inc. (“KR8”) and secured the exclusive license to KR8's AI-based software to support the development and commercial launch of its new health and wellness offering - the VITHAR™ AI Health Coach. As previously announced, the Company is in the process of launchi. 01/22/2024
FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements MINNEAPOLIS--(BUSINESS WIRE)--On November 21, 2023, FOXO Technologies Inc., a Delaware corporation (the “Company”), received an official notice of noncompliance (the “NYSE American Notice”) from NYSE Regulation (“NYSE”) stating that the Company is not in compliance with NYSE American continued listing standards (the “Filing Delinquency Notification”) due to the failure to timely file the Company's Form 10-Q for the period ended September 30, 2023 (the “Delinquent Report”) by the filing due date. 12/19/2023
FOXO Technologies On Track to Commence Commercial Rollout of VITHAR™ AI Health Coach in Early 2024 MINNEAPOLIS--(BUSINESS WIRE)--FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”), a leader in the field of epigenetic biomarker technology, today provided a business update on the planned commercial rollout of its new direct-to-consumer (DTC) app, the VITHAR™ AI Health Coach. The Company also expects to report its financial results for the three and nine months ended September 30, 2023, which the Company anticipates will reflect a reduction in losses in excess of $10 million. 12/01/2023
FOXO Technologies Receives Notice from NYSE American Regarding Late Filing of Quarterly Report on Form 10-Q MINNEAPOLIS--(BUSINESS WIRE)--FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”), a leader in the field of epigenetic biomarker technology, announced that on November 21, 2023, it received a notice from NYSE Regulation stating that the Company is not in compliance with the continued listing standards of the NYSE American (the “Exchange”) under the timely filing criteria set forth in Section 1007 of the NYSE American Company Guide (the “Company Guide”). The non-compliance res. 11/29/2023
FOXO Technologies Provides Reminder for Webinar to be Held Today, November 10th at 10 AM Eastern Time, to Unveil VITHAR™ AI Health Coach MINNEAPOLIS--(BUSINESS WIRE)--FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”), a leader in the field of epigenetic biomarker technology, today provided a reminder that it will host a webinar on Friday, November 10, 2023, at 10 AM Eastern Time, which will be available on the Company's website at https://foxotechnologies.com/. The Company plans to unveil its new direct-to-consumer (DTC) app, the VITHAR™ AI Health Coach, which is designed to intake health data from available. 11/10/2023
FOXO Technologies to Unveil VITHAR™ AI Health Coach; Schedules Webinar for Friday, November 10th at 10 AM Eastern Time MINNEAPOLIS--(BUSINESS WIRE)--FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”), a leader in the field of epigenetic biomarker technology, today announced that it will host a webinar on Friday, November 10, 2023, at 10 AM Eastern Time, which will be available on the Company's website at https://foxotechnologies.com/. The Company plans to unveil its new direct-to-consumer (DTC) app, the VITHAR™ AI Health Coach, which is designed to intake health data from available APIs alre. 11/08/2023
FOXO Technologies Expects Class A Common Stock to Resume Trading, Today, November 7, in Connection with 1-for-10 Reverse Stock Split MINNEAPOLIS--(BUSINESS WIRE)--FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”), a leader in the field of epigenetic biomarker technology, today announced that it expects its Class A common stock (the “Common Stock”) to resume trading today, November 7, 2023, in connection with a 1-for-10 reverse stock split of its issued and outstanding shares of Common Stock to regain compliance with the continued listing requirements, as set forth in Section 1003(f)(v) of the NYSE Americ. 11/07/2023
FOXO Technologies Unveils Plans for New Direct-to Consumer Offering Combining the Company's Epigenetic Data with the Power of AI MINNEAPOLIS--(BUSINESS WIRE)--FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”), a leader in the field of commercializing epigenetic biomarker technology, today announced plans for a new subscription-based, direct-to-consumer product offering that will provide personalized health and wellness recommendations, by combining: (i) FOXO's machine learning models to analyze epigenetic biomarkers; (ii) the Company's expertise and algorithms correlating epigenetic analysis with hea. 10/30/2023
FOXO Technologies Inc. Announces Reverse Stock Split MINNEAPOLIS--(BUSINESS WIRE)--FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”), a leader in the field of commercializing epigenetic biomarker technology, today announced that its Board of Directors has approved a 1-for-10 reverse stock split of the Company's Class A common stock, par value $0.0001 (the “Common Stock”). The reverse stock split will become effective at 4:01pm ET on November 6, 2023. The Common Stock is expected to begin trading on a split-adjusted basis on t. 10/27/2023
FOXO Technologies Completes Strategic Alternatives Review and Outlines Latest Progress Executing Corporate Strategy MINNEAPOLIS--(BUSINESS WIRE)--FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”), a leader in the field of commercializing epigenetic biomarker technology, today announces it has completed its strategic review, following recent management changes, and provided a business update on the Company's progress and plans. Mark White, Interim CEO of FOXO Technologies, stated, “Since taking the helm just over a month ago, FOXO's new management team has initiated a significant restruct. 10/23/2023
FOXO Technologies Announces Issue Notification from USPTO for a Patent Leveraging Machine Learning Approaches to Enable the Commercialization of Epigenetic Biomarkers MINNEAPOLIS--(BUSINESS WIRE)--FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”), a leader in the field of commercializing epigenetic biomarker technology, today announced that the United States Patent & Trademark Office (USPTO) has provided an Issue Notification for a key patent utilizing a machine learning model trained to determine a biochemical state and/or medical condition using DNA epigenetic data to enable the commercialization of epigenetic biomarkers. Previousl. 10/13/2023
FOXO Technologies™ Interim CEO Mark White Provides Letter to Shareholders Outlining New AI-Enabled Direct-to-Consumer Strategy and Immediate Expense Reductions MINNEAPOLIS--(BUSINESS WIRE)--FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”), a leader in the field of commercializing epigenetic biomarker technology, today provided a letter to shareholders from the Company's newly appointed interim CEO, Mark White. “While this has been a turbulent period for the Company, I am honored to take the helm of FOXO Technologies. Before accepting this role, I undertook a comprehensive review of the technology and market potential for FOXO's p. 10/06/2023
FOXO Technologies Announces Agreement With Atrio Insurance MINNEAPOLIS, Minn.--(BUSINESS WIRE)--FOXO Technologies Inc.™ (NYSEAM: FOXO), a technology platform company whose products and services seek to address long-standing, core problems within the life insurance industry through epigenetic longevity science, today announced that its insurance distribution subsidiary, FOXO LIFE™, has engaged Atrio Insurance/Singular Insurance Brokerage, an insurance brokerage general agency offering products and specialty programs throughout the United States, to sell. 09/06/2023
FOXO Technologies Inc. Announces NYSE American Acceptance of Compliance Plan MINNEAPOLIS--(BUSINESS WIRE)--On August 29, 2023, FOXO Technologies Inc. (the “Company”) (NYSEAM: FOXO) received a letter (the “Letter”) from NYSE American LLC (“NYSE American”) stating that NYSE American reviewed and accepted the plan of compliance (the “Plan”) submitted by the Company in response to NYSE American's June 12, 2023 notice (the “Notice”) informing the Company that it was not in compliance with the continued listing standards set forth in Section 1003(a)(i) of the NYSE American Co. 08/31/2023
FOXO Technologies Inc. Announces Receipt of Second Notice of Non-Compliance from NYSE American MINNEAPOLIS--(BUSINESS WIRE)--On August 16, 2023, FOXO Technologies Inc. (NYSEAM: FOXO) (the “Company”) received a second written notice (the “Notice”) from the NYSE American LLC (the “NYSE American”) stating that it is not in compliance with the continued listing standard set forth in Section 1003(f)(v) of the NYSE American Company Guide (the “Company Guide”) because the Company's Class A common stock was selling for a low price per share for a substantial period of time, which NYSE American d. 08/18/2023
FOXO Technologies™ Collaborates with DataRobot to Pave the Way for AI-Driven Epigenetic Biomarker Research in Human Longevity MINNEAPOLIS--(BUSINESS WIRE)--FOXO Technologies Inc. (NYSEAM: FOXO), a leader in the field of commercializing epigenetic biomarker technology, has advanced in its mission to utilize the power of epigenetics and artificial intelligence to generate data-driven insights that promote optimal health and longevity. In collaboration with DataRobot, the leader in Value-Driven AI, FOXO has successfully harnessed the powers of predictive AI and high-throughput automation to estimate factors associated wi. 08/17/2023
How to Spot Multibagger Penny Stocks, 3 Tips and Tricks Use these tips for finding multibagger penny stocks The post How to Spot Multibagger Penny Stocks, 3 Tips and Tricks appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. 01/30/2023
FOXO Technologies Postpones Third Quarter 2022 Earnings Report and Conference Call MINNEAPOLIS--( BUSINESS WIRE )--FOXO Technologies Inc. (NYSEAM: FOXO), a technology platform company whose products and services seek to address long-standing, core problems within the life insurance industry through epigenetic longevity science, today announced that it is postponing its earnings conference call. 11/14/2022
Best Penny Stocks To Buy Right Now? 5 With Big News Today Best Penny Stocks For 2022 Penny stocks aren't a safe haven investment 10/12/2022

Unlock

FOXO Ratings Summary

FOXO Quant Ranking